Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in esophageal squamous cell carcinoma
β Scribed by Hirofumi Uehara; Masaki Miyamoto; Kentaro Kato; Yasushi Cho; Takanori Kurokawa; Soichi Murakami; Akira Fukunaga; Yuma Ebihara; Hiroyuki Kaneko; Hiroyuki Hashimoto; Yosihiro Murakami; Toshiaki Shichinohe; You Kawarada; Tomoo Itoh; Shunichi Okushiba; Satoshi Kondo; Hiroyuki Katoh
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 168 KB
- Volume
- 92
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Transforming growth factorβΞ² (TGFβΞ²) inhibits epithelial cell proliferation. Inactivation of the TGFβΞ² signaling pathway is thought to play a role in tumorigenesis. Our purpose was to clarify the correlation between TGFβΞ² receptors or TGFβΞ²1 expression and the clinicopathologic characte
## Background and objectives: It is generally accepted that the overexpression of p53 protein is associated with poor prognosis in breast, colorectal, and other types of cancer. however, the prognostic significance of p53 aberrations in esophageal squamous cell carcinoma has yet to be determined. w